50mg BD. When used in with a sulphonylurea, the dose is 50mg OD in the morning.
Mode of action
Brands containing this Ingredient
Drug Index 2.0 is hereOur new update features a more powerful search feature and easier login.
issues? Contact us
today. Contact Us
Mode of Action
It is a dipeptidyl peptidase-4 [DPP-4] inhibitor that acts by inhibition of the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.
Allergy to the drug or any other component of the product